pinacidil has been researched along with debrisoquin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Al-Waiz, M; Ayesh, R; Idle, JR; McBurney, A; Mitchell, SC; Smith, RL; Ward, JW | 1 |
Avant, GR; Hamilton, M; Patel, J; Shaheen, O; Wood, AJ | 1 |
3 other study(ies) available for pinacidil and debrisoquin
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Variable metabolism of pinacidil: lack of correlation with the debrisoquine and trimethylamine C- and N-oxidative polymorphisms.
Topics: Adult; Debrisoquin; Female; Guanidines; Humans; Isoquinolines; Male; Methylamines; Middle Aged; Oxidation-Reduction; Phenotype; Pinacidil; Vasodilator Agents | 1989 |
Effect of cirrhosis and debrisoquin phenotype on the disposition and effects of pinacidil.
Topics: Adult; Blood Pressure; Debrisoquin; Drug Interactions; Guanidines; Humans; Isoquinolines; Kinetics; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Phenotype; Pinacidil; Pulse | 1986 |